117 related articles for article (PubMed ID: 9548400)
1. Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.
Kanda T; Kogure S; Nara M; Tsukui S; Utsugi T; Tomono S; Kawazu S; Nagai R; Kobayashi I
Eur J Pharmacol; 1998 Jan; 342(2-3):297-302. PubMed ID: 9548400
[TBL] [Abstract][Full Text] [Related]
2. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
Kanda T; Yokoyama T; Suzuki T; Murata K
Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus.
Yokoyama T; Kanda T; Suzuki T; Murata K
Cardiovasc Drugs Ther; 1991 Apr; 5(2):471-80. PubMed ID: 1713056
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of OK432 and recombinant human interferon alpha A/D on viral myocarditis in mice starting after infection.
Yokoyama T; Kanda T; Suzuki T; Murata K
J Pharmacol Exp Ther; 1991 Sep; 258(3):1114-9. PubMed ID: 1653836
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy with OK432 and recombinant human interferon-alpha A/D on atrial natriuretic peptide gene expression in mice with viral myocarditis.
Kanda T; Yokoyama T; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):494-8. PubMed ID: 7616436
[TBL] [Abstract][Full Text] [Related]
6. Effects of tacrolimus (FK506) on encephalomyocarditic virus-induced diabetes in mice.
Yama S; Nishioka W; Hirokami Y; Setoguchi R; Takeyama N; Saeki K; Matsumoto Y; Hayashi T; Doi K; Onodera T
Microbiol Immunol; 2004; 48(1):7-13. PubMed ID: 14734853
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
[TBL] [Abstract][Full Text] [Related]
8. Induction of virus-induced IDDM in virus resistant mice without lymphocyte maturation.
Kanda T; Utsugi T; Kawazu S; Wilson JE; Yang D; Suarez A; McManus BM; Nagai R; Kobayashi I
Life Sci; 1998; 63(1):33-40. PubMed ID: 9667762
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of branched chain amino acids improves virus-induced glucose intolerance in mice.
Utsugi T; Yoshida A; Kanda T; Kobayashi I; Kurabayashi M; Tomono S; Kawazu S; Tajima Y; Nagai R
Eur J Pharmacol; 2000 Jun; 398(3):409-14. PubMed ID: 10862831
[TBL] [Abstract][Full Text] [Related]
10. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model.
Matsumori A; Crumpacker CS; Abelmann WH
J Am Coll Cardiol; 1987 Jun; 9(6):1320-5. PubMed ID: 3034992
[TBL] [Abstract][Full Text] [Related]
11. Characterization of insulin-dependent diabetes mellitus induced by a new variant (DK-27) of encephalomyocarditis virus in DBA/2 mice.
Dan K; Seto Y; Fujita T; Asaba Y; Takei I; Fujita H; Kato R
Exp Anim; 1995 Jul; 44(3):211-8. PubMed ID: 7556422
[TBL] [Abstract][Full Text] [Related]
12. The significance of T cells, B cells, antibodies and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice.
Kounoue E; Izumi K; Ogawa S; Kondo S; Katsuta H; Akashi T; Niho Y; Harada M; Tamiya S; Kurisaki H; Nagafuchi S
Arch Virol; 2008; 153(7):1223-31. PubMed ID: 18500429
[TBL] [Abstract][Full Text] [Related]
13. The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells.
Kurosawa S; Harada M; Shinomiya Y; Terao H; Nomoto K
Cancer Immunol Immunother; 1996 Sep; 43(1):31-8. PubMed ID: 8917633
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
Yamada T; Matsumori A; Sasayama S
Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.
Sonnenfeld G; Tovey M; Schellekens H; Kinney KS; Belay T; Morton DS; Austin CE; Reitman M; Fong TA; Vaughan HS
J Interferon Cytokine Res; 2001 Jul; 21(7):539-45. PubMed ID: 11506749
[TBL] [Abstract][Full Text] [Related]
16. In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.
Mizutani M; El-Fotoh M; Mori M; Ono K; Doi K; Awaya A; Matsumoto Y; Matsumoto Y; Onodera T
Arch Virol; 1996; 141(1):73-83. PubMed ID: 8629952
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
18. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes.
Hirasawa K; Tsutsui S; Takeda M; Mizutani M; Itagaki S; Doi K
J Gen Virol; 1996 Apr; 77 ( Pt 4)():737-41. PubMed ID: 8627262
[TBL] [Abstract][Full Text] [Related]
19. [Role of interleukin 2 and interferon gamma in induction of activated natural killer cells by the streptococcal preparation OK432].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2504-12. PubMed ID: 2515233
[TBL] [Abstract][Full Text] [Related]
20. Impaired upregulation of Stat2 gene restrictive to pancreatic β-cells is responsible for virus-induced diabetes in DBA/2 mice.
Mine K; Nagafuchi S; Hatano S; Tanaka K; Mori H; Takahashi H; Anzai K; Yoshikai Y
Biochem Biophys Res Commun; 2020 Jan; 521(4):853-860. PubMed ID: 31708097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
